Skip to main content

Table 2 Prevalence of HIV based on selected drug injecting behaviours of IBBS participants, Pokhara Valley (Nepal)

From: Trends and determinants of HIV transmission among men who inject drugs in the Pokhara Valley, Nepal: analysis of cross-sectional studies

 

2003

  

2005

  

2007

  

2009

  

2011

  

2015

  

2017

  

n(a)

N(b)

% (95% CI)

n

N

% (95% CI)

n

N

% (95% CI)

n

N

% (95% CI)

n

N

% (95% CI)

n

N

% (95% CI)

n

N

% (95% CI)

Injected on previous day

 Yes

55

243

22.6 (17.5–28.4)

46

145

31.7 (24.3–40.0)

23

236

9.7 (6.3–14.3)

17

236

7.2 (4.3–11.3)

2

206

1.0 (0.1–3.5)

1

41

2.4 (0.1–12.9)

3

152

2.0 (0.4–5.7)

 No

11

57

19.3 (10.0–31.9)

22

155

14.2 (9.1–20.7)

3

64

4.7 (1.0–13.1)

0

64

0.0 (0.0–5.6)

9

139

6.5 (3.0–11.9)

8

304

2.6 (1.1–5.1)

14

193

7.3 (4.0–11.9)

Recently used unsterilised needles

 Yes

–

–

–

8

37

21.6 (9.8–38.2)

2

20

10.0 (1.2–31.7)

4

28

14.3 (4.0–32.7)

0

6

0.0 (0.0–45.9)

0

34

0.0 (0.0–10.3)

–

–

–

 No

–

–

–

18

263

6.8 (4.1–10.6)

15

280

5.4 (3.0–8.7)

12

317

3.8 (2.0–6.5)

7

244

2.9 (1.2–5.8)

16

292

5.5 (3.2–8.7)

–

–

–

Injected with a used syringe in the past week

 Yes

18

63

28.6 (17.9–41.3)

11

44

25.0 (13.2–40.3)

7

25

28.0 (12.1–49.4)

2

16

12.5 (1.6–38.3)

2

8

25.0 (3.2–65.1)

0

1

0.0 (0.0–97.5)

–

–

–

 No

48

229

21.0 (15.9–26.8)

46

195

23.6 (17.8–30.2)

19

267

7.1 (4.3–10.9)

15

276

5.4 (3.1–8.8)

11

307

3.6 (1.8–6.3)

3

139

2.2 (0.4–6.2)

–

–

–

 Not applicable

0

8

0.0 (0.0–36.9)

8

61

13.1 (5.8–24.2)

0

8

0.0 (0.0–36.9)

0

8

0.0 (0.0–36.9)

3

30

10.0 (2.1–26.5)

3

205

1.5 (0.3–4.2)

–

–

–

Gave needle to someone else after use in last week

 Yes

12

66

18.2 (9.8–29.6)

8

38

21.1 (9.6–37.3)

3

16

18.8 (4.0–45.6)

1

9

11.1 (0.3–48.2)

1

8

12.5 (0.3–52.7)

0

3

0.0 (0.0–70.8)

0

11

0.0 (0.0–28.5)

 No

54

226

23.9 (18.5–30.0)

49

201

24.4 (18.6–30.9)

23

276

8.3 (5.4–12.2)

16

283

5.7 (3.3–9.0)

12

307

3.9 (2.0–6.7)

6

137

4.4 (1.6–9.3)

17

333

5.1 (3.0–8.0)

 Not applicable

0

8

0.0 (0.0–36.9)

8

61

13.1 (5.8–24.2)

0

8

0.0 (0.0–36.9)

0

8

0.0 (0.0–36.9)

3

30

10.0 (2.1–26.5)

0

205

0.0 (0.0–1.8)

0

1

0.0 (0.0–97.5)

Used a pre-filled syringe in past week

 Yes

5

23

21.7 (7.5–43.7)

5

25

20.0 (6.8–40.7)

4

17

23.5 (6.8–49.9)

1

41

2.4 (0.1–12.9)

1

8

12.5 (0.3–52.7)

0

3

0.0 (0.0–70.8)

1

27

3.7 (0.1–19.0)

 No

61

269

22.7 (17.8–28.2)

51

213

23.9 (18.4–30.3)

22

275

8.0 (5.1–11.9)

16

251

6.4 (3.7–10.1)

12

307

3.9 (2.0–6.7)

6

137

4.4 (1.6–9.3)

16

316

5.1 (2.9–8.1)

 Not applicable

0

8

0.0 (0.0–36.9)

8

53

15.1 (6.7–27.6)

0

8

0.0 (0.0–36.9)

0

8

0.0 (0.0–36.9)

3

30

10.0 (2.1–26.5)

0

205

0.0 (0.0–1.8)

0

2

0.0 (0.0–84.2)

Know where to get clean needles

 Yes

66

300

22.0 (17.4–27.1)

65

294

22.1 (17.5–27.3)

24

295

8.1 (5.3–11.9)

17

299

5.7 (3.3–8.9)

16

344

4.7 (2.7–7.4)

9

310

2.9 (1.3–5.4)

17

301

5.6 (3.3–8.9)

 No

0

0

–

0

6

0.0 (0.0–45.9)

2

5

40.0 (5.3–85.3)

0

1

0.0 (0.0–97.5)

0

1

0.0 (0.0–97.5)

0

35

0.0 (0.0–10.0)

0

44

0.0 (0.0–8.0)

Average age at first injection

 Above median

30

169

17.8 (12.3–24.4)

35

152

23.0 (16.6–30.5)

17

153

11.1 (6.6–17.2)

11

169

6.5 (3.3–11.3)

13

178

7.3 (3.9–12.2)

2

196

1.0 (0.1–3.6)

   

 Below median

36

131

27.5 (20.0–36.0)

3

148

2.0 (0.4–5.8)

9

147

6.1 (2.8–11.3)

6

131

4.6 (1.7–9.7)

3

167

1.8 (0.4–5.2)

7

149

4.7 (1.9–9.4)

13

164

7.9 (4.3–13.2)

Total

66

300

22.0 (17.4–27.1)

65

300

21.7 (17.1–26.7)

26

300

8.7 (5.7–12.4)

17

300

5.7 (3.3–8.9)

16

345

11.3 (2.7–7.4)

9

345

2.6 (1.2–4.9)

17

345

4.9 (2.9–7.8)

  1. n Number of HIV cases, N Total number of participants, IBBS Integrated Biological Behavioural Surveys